Mr Hugh Mostafid
Qualifications
MSc, FRCS (Urol), FEBU
GMC number: 3337062
Practising since: 1989
Specialties
Urology
Consultation times
- Guildford: Thurs 12:30 - 13:30
- Woking: Fridays 13:00 - 14:00
- Overview
Or call us on
About
In 2014 he was a visiting scholar at the Department of Urology at the University of California in Los Angeles to learn robotic surgery techniques. He is also an Honorary Senior Lecturer in the Faculty of Health and Medical Sciences at the University of Surrey in Guildford.
His main clinical and interests are bladder cancer, stone disease and urinary tract infection. He was one of the first UK urologists to introduce blue light cystoscopy and device assisted intravesical therapy for bladder cancer. His main research interests are the diagnosis and treatment of bladder cancer.
He is the Chief Investigator for CALIBER, a national bladder cancer trial funded £360,000 by the DoH, co-applicant in 3 other national bladder cancer trials and a leading recruiter into national and international bladder cancer trials. He is also an expert advisor to NICE on bladder cancer, a member of the European Association of Urology Bladder Cancer guidelines panel and a faculty member of the European School of Urology. He was a founder member and past Chair of Bladder Cancer UK, a charity which was set up to raise funds for bladder cancer research and improve patient outcomes in the UK.
He is also a past member of the National Cancer Research Institute's Bladder Cancer clinical study group, the NICE bladder cancer guidelines group and the NHS England specialised urology clinical reference group.
Special interests
- Bladder Cancer
- Kidney Stones
- Urinary Tract Infection
Treatments and tests offered by Mr Hugh Mostafid at Nuffield Health
- Transurethral resection of bladder tumour (TURBT)
- Prostate surgery
- Cystoscopy
- Circumcision
- Prostate resection (TURP)
- Orchidectomy
Locations Mr Hugh Mostafid works with
Related experience
Research
His main research interests are the diagnosis and treatment of bladder cancer. He is the Chief Investigator for CALIBER, a national bladder cancer trial funded £360,000 by the DoH, chief investigator for several national bladder cancer trials and a leading recruiter into national and international bladder cancer trials. He is also an expert advisor to NICE on bladder cancer, a member of the European Association of Urology Bladder Cancer guidelines panel. He was a founder member and past Chair of Bladder Cancer UK, a charity which was set up to raise funds for bladder cancer research and improve patient outcomes in the UK. He is also a past member of the National Cancer Research Institute's Bladder Cancer clinical study group, the NICE bladder cancer guidelines group and the NHS England specialised urology clinical reference group. He has published over 70 papers and written book chapters on bladder cancer as well as being as invited speaker at national and international meetings on bladder cancer.
Memberships
- British Association of Urology Surgeons
- European Association of Urology
- European School of Urology
- Royal College of Surgeons
Other posts held
- Consultant Urological Surgeon and Honorary Senior Lecturer at Royal Surrey County Hospital
Insurers Mr Hugh Mostafid works with
Mr Hugh Mostafid works with the following private medical insurance providers:
- Westfield Health WPA
- Aviva Health
- AXA Health
- Benenden Health
- Bupa
- Cigna
- Simplyhealth
- Vitality Health (Pru Health)
- AXA - Global Healthcare
- CS Healthcare
- Exeter Family Friendly
- Health-on-Line
Declaration
Mr Hugh Mostafid does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Mr Hugh Mostafid does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Mr Hugh Mostafid does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.